AI assistant
MYRIAD GENETICS INC — Director's Dealing 2019
Sep 26, 2019
32566_dirs_2019-09-26_94f0d643-2544-45d0-8d9c-373cff06b434.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2019-09-25
Reporting Person: Jackson Benjamin (E.V.P., General Counsel)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-09-25 | Common Stock | D | 367 | $29.93 | Disposed | 17282 | Direct |
| 2019-09-25 | Common Stock | D | 453 | $29.93 | Disposed | 16829 | Direct |
| 2019-09-25 | Common Stock | A | 40000 | $0.0 | Acquired | 56829 | Direct |
Footnotes
F1: Represents shares withheld by the Company to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the reporting person.
F2: Consists of restricted stock units granted pursuant to the Company's 2017 Employee, Director and Consultant Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one share of the Company's common stock and vests 25% on September 26, 2020, 25% on September 26, 2021, 25% on September 26, 2022, and 25% on September 26, 2023.